In her latest On target column published by the ESMO Daily Reporter, VHIO’s Elena Garralda discusses the expanding toolbox for immuno-oncology in advanced…
Early Clinical Drug Development Group
Published by ESMO’s Daily Reporter, Elena Garralda’s latest On target column explores the promise of neoadjuvant immunotherapy in the treatment…
The predictability of response criteria remains controversial in drug development. Numerous reviews and meta-analyses continue to question the reliability of…
In her latest On target column, published by ESMO’s Daily Reporter, VHIO’s Elena Garralda reflects on the myriad research advances presented at last month’s…
The kick-off meeting of PragmaTIL, a project that will finance a pioneering academic clinical trial in advanced therapies, coordinated by…
In her latest On target column, author Elena Garralda, Executive Director of VHIO’s Research Unit for Molecular Therapy of Cancer…
Now published by the ESMO Daily Reporter (formerly by the ESMO Perspectives online magazine), the latest edition of On Target – Gathering…
